Morgan Stanley has released a research report indicating that the Finance Ministry's capital injections into state-owned insurance companies over the past weekend are expected to have a neutral impact, with the market's attention now shifting to the final funding structure, capital deployment plans, and pricing mechanisms.
The investment bank noted that China Life Group, PICC Group, and Taiping Group received capital injections of 35 billion yuan, 15 billion yuan, and 7 billion yuan respectively from the Finance Ministry. PICC Group has announced an A-share private placement, which is projected to raise its group capital adequacy ratio by 6.1 percentage points while simultaneously creating a dilution effect of approximately 4.4%.
Morgan Stanley believes that PICC Group's projected 47% growth in earnings per share for the first half of 2026 already accounts for the potential dilution impact, and this fundraising initiative can support the company's future business development. As for the other two insurers, the capital injections occur at the group level, leaving the implications for their listed entities still unclear.
The firm assesses the overall impact as neutral, with future attention focused on the specific funding structure, capital usage, and pricing terms. For PICC Group, assuming the issuance is priced at the 20-day average price, Morgan Stanley estimates approximately 2.02 billion new shares will be issued, equivalent to 4.6% of the expanded share capital, implying a dilution of roughly 4.4% to both earnings per share and dividends per share, which the bank considers to be within a manageable range.
In the case of China Life Group, since the capital injection remains at the group level and the use of funds has not yet been disclosed, the impact on the listed entity and potential dilution remains uncertain. However, China Life's capital position is already strong, with a core solvency ratio of 157% and a comprehensive solvency ratio of 198% as of the first half of 2026, while the group and certain subsidiaries, including property and casualty insurance, annuity, and overseas operations, may have greater capital needs. Under an extreme scenario, Morgan Stanley estimates potential dilution for China Life of 3.2% based on the 20-day average price, though the actual dilution could be lower.